Core Viewpoint - Haijia Medical (06078) anticipates a decline in revenue and net profit for 2025, primarily due to goodwill impairment and increased operational costs [1] Financial Projections - The company expects revenue for 2025 to be approximately RMB 4.0–4.5 billion, representing a year-on-year decrease of about 9% to 10% [1] - Net profit is projected to be around RMB 140–200 million, reflecting a significant year-on-year decline of approximately 66% to 76% [1] - Adjusted net profit is estimated at RMB 450–490 million, indicating a year-on-year decrease of about 19% to 25% [1] - Cash generated from operating activities is expected to be between RMB 940–1,000 million, showing a year-on-year increase of approximately 33% to 41% [1] Factors Influencing Performance - The decline in revenue, net profit, and adjusted net profit is attributed to industry and macroeconomic impacts, as well as increased startup costs and depreciation expenses from newly opened hospitals [1] - The anticipated drop in net profit for the year ending December 31, 2025, is also significantly influenced by the goodwill impairment provision related to Etern Group Ltd. [1] - The company has conducted a careful assessment of its operational and financial performance, along with future business prospects, to determine the necessity and amount of the impairment and provision [1]
海吉亚医疗发盈警 预期2025年净利润约为1.4–2.0亿元 同比下降约66%至76%